We are actively pursuing opportunities to expand our R&D pipeline, with a strategic focus on addressing unmet medical needs in childhood cancers and orphan diseases.

Our current R&D pipeline is focused on innovative drugs in the areas of cancers (including childhood cancers), central nervous system diseases and hepatic diseases.

Information on clinical trials associated with our development are available in the links provided below.

OP-10：Phase I / II
https://jrct.mhlw.go.jp/latest-detail/jRCT2080225115

OP-10：Phase III （Chimerix Inc.）
https://jrct.mhlw.go.jp/latest-detail/jRCT2051240141

OP-2100：Phase I
https://jrct.mhlw.go.jp/latest-detail/jRCT2071220035

OP-724-002：Phase II
https://jrct.mhlw.go.jp/latest-detail/jRCT2031230195

OP-2024：Phase III
https://jrct.mhlw.go.jp/latest-detail/jRCT2021240047